These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33488516)

  • 1. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
    Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
    Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors.
    Cirello V
    Minerva Endocrinol (Torino); 2021 Mar; 46(1):5-20. PubMed ID: 33045820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
    Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.
    Colombo C; Muzza M; Proverbio MC; Ercoli G; Perrino M; Cirello V; Vicentini L; Ferrero S; Fugazzola L
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):837-844. PubMed ID: 28222214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BROX haploinsufficiency in familial nonmedullary thyroid cancer.
    Pasquali D; Torella A; Accardo G; Esposito D; Del Vecchio Blanco F; Salvatore D; Sabatino P; Pacini F; Barbato F; Castagna MG; Cantara S; Nigro V
    J Endocrinol Invest; 2021 Jan; 44(1):165-171. PubMed ID: 32385852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
    Zhang T; Xing M
    J Natl Cancer Inst; 2016 Jun; 108(6):djv415. PubMed ID: 26832773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.
    Weeks AL; Wilson SG; Ward L; Goldblatt J; Hui J; Walsh JP
    BMC Med Genet; 2016 Aug; 17(1):60. PubMed ID: 27530615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial non-medullary thyroid cancer: unraveling the genetic maze.
    Peiling Yang S; Ngeow J
    Endocr Relat Cancer; 2016 Dec; 23(12):R577-R595. PubMed ID: 27807061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al.
    Colombo C; Fugazzola L; Muzza M; Proverbio MC; Cirello V
    Eur J Med Genet; 2018 Feb; 61(2):104-105. PubMed ID: 28779995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
    Pereira JS; da Silva JG; Tomaz RA; Pinto AE; Bugalho MJ; Leite V; Cavaco BM
    Endocrine; 2015 May; 49(1):204-14. PubMed ID: 25381600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer?
    Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M
    Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update].
    Valdes-Socin H; Palmeira L; Burlacu MC; Daly AF; Bours V; Beckers A
    Rev Med Liege; 2016 Dec; 71(12):557-561. PubMed ID: 28387096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of pediatric familial non-medullary thyroid cancer (FNMTC).
    Capezzone M; Maino F; Sagnella A; Campanile M; Dalmiglio C; Pilli T; Forleo R; Castagna MG
    J Endocrinol Invest; 2021 Oct; 44(10):2319-2321. PubMed ID: 33580435
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer.
    Bann DV; Jin Q; Sheldon KE; Houser KR; Nguyen L; Warrick JI; Baker MJ; Broach JR; Gerhard GS; Goldenberg D
    Cancer Res; 2019 Nov; 79(21):5490-5499. PubMed ID: 31501191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?
    Kim YS; Seo M; Park SH; Ju SY; Kim ES
    World J Surg; 2020 Sep; 44(9):3022-3027. PubMed ID: 32556933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function.
    Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM
    J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
    Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH
    Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
    Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
    Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of
    Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
    Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.